Editorial: Insomnia.
D001049:Apnea / Q000139:chemically induced / Q000150:complications; D002908:Chronic Disease; D005479:Flurazepam / Q000627:therapeutic use; D006801:Humans; D006993:Hypnotics and Sedatives / Q000009:adverse effects; D007049:Iatrogenic Disease; D008297:Male; D008875:Middle Aged; D007319:Sleep Initiation and Maintenance Disorders / Q000139:chemically induced / Q000150:complications / Q000188:drug therapy*; D012895:Sleep, REM; D013375:Substance Withdrawal Syndrome / Q000188:drug therapy; D019966:Substance-Related Disorders; D013577:Syndrome; D013997:Time Factors; D014851:Wakefulness
D006993:Hypnotics and Sedatives; D005479:Flurazepam